您当前的位置：
首页 >
文章列表页 >
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis： A Review
更新时间：2026-04-01

    • Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis： A Review

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 9, Pages: 276-283(2026)

    • DOI：10.13422/j.cnki.syfjx.20251241    

      CLC： R282;R242;R259

    • Received：09 May 2025，

      Revised：2025-06-05，

      Accepted：11 June 2025，

      Online First：17 June 2025，

      Published：05 May 2026

    移动端阅览

  • QIU Shuxuan,GUO Lin,WANG Ruiying,et al.Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(09):276-283. DOI： 10.13422/j.cnki.syfjx.20251241.

  •  
  •  

0

Views

10

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Diaphragmatic Dysfunction in Chronic Obstructive Pulmonary Disease and Treatment with Traditional Chinese Medicine： A Review
Traditional Chinese Medicine Treats Hepatic Fibrosis via NF-κB Signaling Pathway： A Review
Traditional Chinese Medicine Against Liver Fibrosis Based on Autophagy： A Review

Related Author

YING Yuanyuan
ZHOU Xiaoqing
NI Kaiwen
WANG Zhen
LI Zishun
ZHAO Changpu
CHEN Renwu
LI Meiling

Related Institution

The First Affiliated Hospital of Zhejiang Chinese Medical University/ Zhejiang Provincial Hospital of Chinese Medicine
The First Clinical Medical School of Zhejiang Chinese Medical University
The Second Clinical Medical School of Henan University of Chinese Medicine
Henan Provincial Hospital of Traditional Chinese Medicine
Gansu University of Chinese Medicine
0